New animal models for hepatitis C viral infection and pathogenesis studies.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  World Journal of Gastroenterology

• Publication date

  2007-05-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3748/WJG.V13.I17.2427PMID 17552025PMCID PMC4146760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• References Subscriptions Permissions Email Alerts Cell-Dependent Liver Damage T Fas Ligand Is Responsible for CXCR3 Chemokine Induction in CD4 +

  2013cited by this paper
• Development of humanized mice for the study of hepatitis C virus infection.

  2006cited by this paper
• Liver-stage development of Plasmodium falciparum, in a humanized mouse model.

  2006cited by this paper
• Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

  2006cited by this paper
• Application of functional genomics to the chimeric mouse model of HCV infection: optimization of microarray protocols and genomics analysis

  2006cited by this paper
• The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor α mediated liver disease

  2006cited by this paper
• Host-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune Response

  2006cited by this paper
• Anti‐HCV therapies in chimeric scid‐Alb/uPA mice parallel outcomes in human clinical application

  2006cited by this paper
• Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.

  2006cited by this paper
• Fas Ligand Is Responsible for CXCR3 Chemokine Induction in CD4+ T Cell-Dependent Liver Damage1

  2006cited by this paper
• Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray

  2006cited by this paper
• A novel immunocompetent rat model of HCV infection and hepatitis.

  2005cited by this paper
• A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins

  2005cited by this paper
• Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2.

  2005cited by this paper
• Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus

  2005cited by this paper
• Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression.

  2005cited by this paper
• Hepatitis C Virus Core Protein Inhibits Mitochondrial Electron Transport and Increases Reactive Oxygen Species (ROS) Production*

  2005cited by this paper
• Upregulation of Protein Phosphatase 2Ac by Hepatitis C Virus Modulates NS3 Helicase Activity through Inhibition of Protein Arginine Methyltransferase 1

  2005cited by this paper
• Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis

  2005cited by this paper
• Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes.

  2005cited by this paper
• Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH.

  2005cited by this paper
• Hepatitis C Virus Infection Can Present with Metabolic Disease by Inducing Insulin Resistance

  2005cited by this paper
• Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion

  2005cited by this paper
• STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

  2005cited by this paper
• Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell‐dependent hepatic inflammation

  2005cited by this paper
• Morphological and biochemical characterization of a human liver in a uPA‐SCID mouse chimera

  2005cited by this paper
• Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase.

  2004cited by this paper
• Development of a GB Virus B Marmoset Model and Its Validation with a Novel Series of Hepatitis C Virus NS3 Protease Inhibitors

  2004cited by this paper
• Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.

  2004cited by this paper
• In Vivo Analysis of the 3′ Untranslated Region of GB Virus B after In Vitro Mutagenesis of an Infectious cDNA Clone: Persistent Infection in a Transfected Tamarin

  2004cited by this paper
• Transgenic expression of Korean type hepatitis C virus core protein and related mutants in mice

  2004cited by this paper
• Hepatitis C Virus Infection Activates the Immunologic (Type II) Isoform of Nitric Oxide Synthase and Thereby Enhances DNA Damage and Mutations of Cellular Genes

  2004cited by this paper
• Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.

  2004cited by this paper
• Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A.

  2004cited by this paper
• Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice.

  2004cited by this paper
• Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein.

  2004cited by this paper
• Near completely humanized liver in mice shows human-type metabolic responses to drugs.

  2004cited by this paper
• Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice

  2003cited by this paper
• Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice

  2003cited by this paper
• Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice.

  2003cited by this paper
• Expression of hepatitis C virus non‐structural 5A protein in the liver of transgenic mice

  2003cited by this paper
• Hepatitis C virus infection and liver steatosis.

  2003cited by this paper
• Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia.

  2003cited by this paper
• Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model.

  2003cited by this paper
• Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice.

  2003cited by this paper
• The Hepatitis C Virus NS2 Protein Is an Inhibitor of CIDE-B-induced Apoptosis*

  2003cited by this paper
• Induction of hepatic injury by hepatitis C virus-specific CD8+ murine cytotoxic T lymphocytes in transgenic mice expressing the viral structural genes.

  2003cited by this paper
• The hepatitis C virus (HCV)-Trimera mouse: a model for evaluation of agents against HCV.

  2002cited by this paper
• Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: Safety and antiviral properties

  2002cited by this paper
• Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.

  2002cited by this paper
• Lack of susceptibility of Chacma baboons (Papio ursinus orientalis) to hepatitis C virus infection

  2002cited by this paper
• Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation

  2002cited by this paper
• Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral‐related steatosis

  2002cited by this paper
• Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein.

  2002cited by this paper
• Interaction of hepatitis C virus core protein with retinoid X receptor α modulates its transcriptional activity

  2002cited by this paper
• Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein.

  2002cited by this paper
• Hepatitis C Virus Core Protein Leads to Immune Suppression and Liver Damage in a Transgenic Murine Model

  2002cited by this paper
• Hepatitis C virus replication in mice with chimeric human livers

  2001cited by this paper
• Transplantation of human hepatocytes into tolerized genetically immunocompetent rats.

  2001cited by this paper
• Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

  2001cited by this paper
• Model for Hepatitis C Virus-associated Hepatocarcinogenesis Oxidative Stress in the Absence of Inflammation in a Mouse Updated

  2001cited by this paper
• Inhibition of Cytochrome c Release in Fas-mediated Signaling Pathway in Transgenic Mice Induced to Express Hepatitis C Viral Proteins*

  2001cited by this paper
• Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humans.

  2001cited by this paper
• Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation

  2001cited by this paper
• Preclinical Evaluation of Two Human Anti–Hepatitis B Virus (HBV) Monoclonal Antibodies in the HBV‐Trimera Mouse Model and in HBV Chronic Carrier Chimpanzees

  2000cited by this paper
• HCV-core protein accelerates recovery from the insensitivity of liver cells to Fas-mediated apoptosis induced by an injection of anti-Fas antibody in mice.

  2000cited by this paper
• Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system

  2000cited by this paper
• Hepatitis C virus structural proteins induce liver cell injury in transgenic mice

  1999cited by this paper
• Transmission of hepatitis C virus infection to tree shrews.

  1998cited by this paper
• The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

  1998cited by this paper
• Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma.

  1998cited by this paper
• Efficient Conditional Transgene Expression in Hepatitis C Virus cDNA Transgenic Mice Mediated by the Cre/loxP System*

  1998cited by this paper
• Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes.

  1997cited by this paper
• Hepatitis C virus core and E2 protein expression in transgenic mice

  1997cited by this paper
• Transgenic expression of hepatitis C virus structural proteins in the mouse

  1997cited by this paper
• Lack of susceptibility of the cottontop tamarin to hepatitis C infection

  1997cited by this paper
• Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

  1997cited by this paper
• Expression of hepatitis C virus envelope proteins in transgenic mice.

  1995cited by this paper
• Identification of two flavivirus-like genomes in the GB hepatitis agent.

  1995cited by this paper
• Hepatitis C virus viremia in SCID-->BNX mouse chimera.

  1995cited by this paper
• Replacement of diseased mouse liver by hepatic cell transplantation.

  1994cited by this paper
• Lack of susceptibility of various primates and woodchucks to hepatitis C virus.

  1993cited by this paper
• Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene.

  1991cited by this paper
• Engraftment and development of human T and B cells in mice after bone marrow transplantation.

  1991cited by this paper
• Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator.

  1990cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper
• Non-A, non-B viral hepatitis

  1984cited by this paper
• Non-A, non-B hepatitis in chimpanzees and marmosets.

  1981cited by this paper
• Transmissible agent in non-A, non-B hepatitis.

  1978cited by this paper
• Non-A, non-B hepatitis.

  1976cited by this paper
• Transfusion‐associated hepatitis not due to viral hepatitis type A or B †

  1975cited by this paper

• Modeling Liver Development and Disease in a Dish

  2023cites this paper
• Animal Models of Hepatitis C Virus Infection.

  2019cites this paper
• Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models

  2019cites this paper
• Hepatitis C Virus Infection and Vaccine Development.

  2018cites this paper
• The effect of JAK2 knockout on inhibition of liver tumor growth by inducing apoptosis, autophagy and anti-proliferation via STATs and PI3K/AKT signaling pathways.

  2016cites this paper
• New Animal Models for Hepatitis C

  2016cites this paper
• Modeling of HBV and HCV hepatitis with hepatocyte-like cells.

  2016cites this paper
• Biochemical Profiling and Synergistic Potential of Medicinal Plants as Hepatoprotective

  2015cites this paper
• Progress in the development of vaccines for hepatitis C virus infection.

  2015cites this paper
• Development of novel model systems to assess replication of patient derived hepatitis C virus in tissue culture

  2015cites this paper
• Generation of liver-specific TGF-α and c-Myc-overexpressing fibroblasts for future creation of a liver cancer porcine model.

  2014cites this paper
• Visualizing hepatitis C virus infection in humanized mice.

  2014cites this paper
• Characterization of major histocompatibility complex class I allele polymorphisms in common marmosets.

  2014cites this paper
• Production and pathogenicity of hepatitis C virus core gene products.

  2014cites this paper
• Characterization of fluorescently-labeled hepatitis C virus genomes and their application to visualize the intracellular transport of viral particles

  2014cites this paper
• Investigating Host-Viral Interactions in Liver Lipid Homeostasis and HCV Pathology

  2014cites this paper
• Animal models for hepatitis C.

  2013cites this paper
• Development of murine models to study Hepatitis C virus induced liver pathogenesis

  2013cites this paper
• Animal Models of human Cancer

  2013cites this paper
• Both core and F proteins of hepatitis C virus could enhance cell proliferation in transgenic mice.

  2013cites this paper
• Animal models of chronic liver diseases.

  2013cites this paper
• Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections

  2012cites this paper
• Développement d'immunothérapies du carcinome hépatocellulaire et de l'infection par le virus de l'hépatite C

  2012cites this paper
• Pharmacogenetic selection of transplanted human hepatocytes in immunocompetent rats

  2012cites this paper
• Investigating virus entry using cell-culture adapted hepatitis C virus

  2012cites this paper
• Rodent Models with Humanized Liver: A Tool to Study Human Pathogens

  2012cites this paper
• Conditional gene expression in hepatitis C virus transgenic mice without induction of severe liver injury using a non-inflammatory Cre-expressing adenovirus.

  2011cites this paper
• Experimental models to study the immunobiology of hepatitis C virus.

  2011cites this paper
• Development of a Hepatitis C Virus knowledgebase with computational prediction of functional hypothesis of therapeutic relevance

  2011cites this paper
• Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals.

  2011cites this paper
• HCV interferiert mit Ack1-abhängigen Signalwegen durch Herabregulation der TC-PTP

  2011influential citation
• Rodent models of liver repopulation.

  2010cites this paper
• Effects of HCV proteins in current HCV transgenic models

  2010cites this paper
• Effect of Hepatitis C Virus Infection on the mRNA Expression of Drug Transporters and Cytochrome P450 Enzymes in Chimeric Mice with Humanized Liver

  2010cites this paper
• Fitness and infectivity of drug-resistant and cross-resistant hepatitis B virus mutants: why and how is it studied?

  2010cites this paper
• Molecular and functional genetics of hepatocellular carcinoma.

  2010cites this paper
• Rôle des lipoprotéines associées au virus de l'hépatite C et des microtubules dans l'entrée du virus dans la cellule et l'établissement de l'infection

  2010cites this paper
• Investigating the interaction between the Hepatitis C virus core protein and the cellular DEAD-box protein DDX3 and its importance in virus replication

  2010cites this paper
• An Assessment of the Use of Chimpanzees in Hepatitis C Research Past , Present and Future : 1 . Validity of the Chimpanzee Model

  2010cites this paper
• An Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 1. Validity of the Chimpanzee Model

  2010cites this paper
• Experimental models for hepatitis C viral infection

  2009cites this paper
• Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees (cid:1)

  2009cites this paper
• Stem cells and the liver: clinical applications in transplantation.

  2009cites this paper
• Development of novel treatments for hepatitis C.

  2009cites this paper
• Treatment of hepatitis C virus core-positive hepatocytes with the transfer of recombinant caspase-3 using the 2',5'-oligoadenylate synthetase gene promoter.

  2009cites this paper
• Non‐human primate surrogate model of hepatitis C virus infection

  2009cites this paper
• Mouse models in liver cancer research: a review of current literature.

  2008cites this paper
• Mouse models for the study of HCV infection and virus–host interactions

  2008cites this paper
• Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees

  2008cites this paper
• Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens

  2008cites this paper
• Fitness and infectivity of drug-resistant and cross-resistant HBV mutants : why and how is it studied ?

  year unknowncites this paper